ARMISTICE CAPITAL, LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Verrica Pharmaceuticals Inc. Common Stock, $0.0001 par value (VRCA)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: Verrica Pharmaceuticals Inc. Common Stock, $0.0001 par value
Symbol: VRCA
Shares outstanding: 92,448,158 shares
Disclosed Ownership: 9,235,571 shares
Ownership: 10%
Form type: SCHEDULE 13G/A
Filing time: 14 Aug 2025, 21:41:34 UTC
Date of event: 31 Mar 2025
Previous filing: 14 Feb 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	10%	9,235,571	0	9,235,571	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	10%	9,235,571	0	9,235,571	/s/ Steven Boyd	Steven Boyd